Cargando…
Erythrocyte pyruvate kinase deficiency: 2015 status report
Over the last several decades, our understanding of the genetic variation, pathophysiology, and complications of the hemolytic anemia associated with red cell pyruvate kinase deficiency (PKD) has expanded. Nonetheless, there remain significant gaps in our knowledge with regard to clinical care and m...
Autores principales: | Grace, Rachael F., Zanella, Alberto, Neufeld, Ellis J., Morton, D. Holmes, Eber, Stefan, Yaish, Hassan, Glader, Bertil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053227/ https://www.ncbi.nlm.nih.gov/pubmed/26087744 http://dx.doi.org/10.1002/ajh.24088 |
Ejemplares similares
-
Comorbidities and complications in adults with pyruvate kinase deficiency
por: Boscoe, Audra N., et al.
Publicado: (2021) -
The variable manifestations of disease in pyruvate kinase deficiency and their management
por: Al-Samkari, Hanny, et al.
Publicado: (2020) -
The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design
por: Grace, Rachael F, et al.
Publicado: (2023) -
Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency
por: Al-Samkari, Hanny, et al.
Publicado: (2022) -
Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD
por: Schwartz, Jonathan D., et al.
Publicado: (2022)